201 related articles for article (PubMed ID: 2971365)
1. T-cell subsets in peripheral blood of patients with newly diagnosed and posttreatment Hodgkin's and non-Hodgkin's lymphomas. Analysis by monoclonal antibody staining and flow cytometry.
De Angelis P; Kimmel M; Lacher M; Filippa D; Melamed MR
Anal Quant Cytol Histol; 1988 Aug; 10(4):235-42. PubMed ID: 2971365
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the circulating and splenic lymphocyte subpopulations in patients with non-Hodgkin lymphomas and Hodgkin's disease using monoclonal antibodies.
Herrmann F; Sieber G; Jauer B; Lochner A; Komischke B; Rühl H
Blut; 1983 Jul; 47(1):41-51. PubMed ID: 6222774
[TBL] [Abstract][Full Text] [Related]
3. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
Knowles DM; Halper JP; Jakobiec FA
Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
[TBL] [Abstract][Full Text] [Related]
4. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subpopulations in Hodgkin's disease and non-Hodgkin's lymphoma and the effects of radiotherapy.
Balasem AN; Barker CR
Clin Radiol; 1984 Sep; 35(5):353-7. PubMed ID: 6236011
[TBL] [Abstract][Full Text] [Related]
6. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
8. Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas.
Diaz JI; Edinger MG; Stoler M; Tubbs RR
Leuk Lymphoma; 1993 Jan; 9(1-2):85-90. PubMed ID: 8477206
[TBL] [Abstract][Full Text] [Related]
9. Serum from patients with non-Hodgkin's lymphoma (NHL) inhibits T-cell colony formation.
Hutchison RE; Tice DG; Davey FR
Am J Hematol; 1987 Jun; 25(2):143-53. PubMed ID: 2955696
[TBL] [Abstract][Full Text] [Related]
10. T-cell subsets in malignant lymphomas and monoclonal gammopathies.
Bergmann L; Mitrou PS; Kelker W; Weber KC
Scand J Haematol; 1985 Feb; 34(2):170-6. PubMed ID: 3156399
[TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
Faure M; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
[TBL] [Abstract][Full Text] [Related]
12. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
13. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
[TBL] [Abstract][Full Text] [Related]
14. Circulating lymphocyte populations in Hodgkin's disease after mantle and paraaortic irradiation.
Posner MR; Reinherz E; Lane H; Mauch P; Hellman S; Schlossman SF
Blood; 1983 Apr; 61(4):705-8. PubMed ID: 6219724
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
16. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
17. Granulomonopoiesis and production of granulomonopoietic regulating factors in Hodgkin's disease and non-Hodgkin's lymphomas.
Lòpez-Karpovitch X; Càrdenas MR; Lobato-Mendizabal E; Piedras J
Ann N Y Acad Sci; 1989; 554():241-7. PubMed ID: 2660676
[TBL] [Abstract][Full Text] [Related]
18. A quantitative comparison of T-cell subsets in Hodgkin's disease and reactive hyperplasia. Frozen section immunohistochemistry.
Martin JM; Warnke RA
Cancer; 1984 Jun; 53(11):2450-5. PubMed ID: 6231984
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease in AIDS complex patients. Report of four cases and tissue immunologic marker studies.
Unger PD; Strauchen JA
Cancer; 1986 Aug; 58(4):821-5. PubMed ID: 2941139
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
